nemiDD

CTXR Chart Looks Nice + Upcoming Catalyst

Long
NASDAQ:CTXR   Citius Pharmaceuticals, Inc.
Analyzing volume using 1hr candles. Take Aways:

1) Consolidating b/t 1.86 to 1.97 -> Needs to break over 2.02 for uptrend confirmation per fib levels
2) Price targets are 2.22 & 2.40 -> take 50% profit at 2.22 and let rest ride
2) Set SL @ 1.86 for a tight SL, @ 1.58 for loose, and @ 1.35 if you're portfolio can handle the choppiness we're in
3) Mino-lok goes for FDA approval late April. Nearest competition $CRMD failed approval roughly a month ago and dropped 60% on the news so please do not go full port on this

This is not financial advice and should only be used for entertainment purposes. Do your own due diligence.
Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.